Please enter a valid ZIP code

Safety in controlling a bleed with NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Why viral safety is important

Viral Viral
Caused by a virus.
safety of NovoSeven® RT means eliminating exposure to viruses Virus
A pathogen or carrier of disease that enters healthy cells and reproduces in large numbers, which then spread through the bloodstream.
that are passed through human blood. Viral safety is very important for anyone with a bleeding disorder.

NovoSeven® RT is a recombinant Recombinant
Genetically engineered DNA. Made without human blood or plasma.
product. This means it is made without any human blood or plasma Plasma
The fluid part of the blood that contains clotting factors and other proteins.
. So you can feel safe knowing that NovoSeven® RT works without the risk of viruses that are passed through human blood.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information

WARNING: BLOOD CLOTS

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported.
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function.
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT.

Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.